Table 4 Logistic regression analysis for risk factors of sarcopenia patients.
From: The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study
Characteristics | Univariate | Multi-variate | ||
|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |
Age (year) | ||||
≦65 | Reference | Reference | ||
>65 | 2.81 (1.47–5.4) | 0.002** | 2.46 (1.20–5.06) | 0.014* |
Sex | ||||
Female | Reference | Reference | ||
Male | 2.65 (1.65–4.28) | < 0.001*** | 2.08 (1.11–3.91) | 0.023* |
BMI (kg/m2) | ||||
≦28 | Reference | Reference | ||
> 28 | 0.20 (0.07–0.55) | 0.002** | 0.18 (0.06–0.53) | 0.002** |
Fat percentage (%) | ||||
≦35 | Reference | Reference | ||
> 35 | 0.53 (0.33–0.85) | 0.008** | 0.99 (0.53–1.83) | 0.968 |
TC (mmol/L) | ||||
≦0.46 | Reference | Reference | ||
> 0.46 | 0.46 (0.27–0.76) | 0.003** | 0.46 (0.22–0.97) | 0.042* |
TG (mmol/L) | ||||
≦0.41 | Reference | Reference | ||
> 0.41 | 0.41 (0.25–0.65) | < 0.001*** | 0.52 (0.30–0.90) | 0.019* |
HDL (mmol/L) | ||||
≦0.72 | Reference | |||
> 0.72 | 0.72 (0.39–1.33) | 0.295 | ||
LDL (mmol/L) | ||||
≦0.51 | Reference | Reference | ||
> 0.51 | 0.51 (0.32–0.81) | 0.004** | 1.23 (0.60–2.52) | 0.568 |
HCY (umol/L) | ||||
≦2.94 | Reference | Reference | ||
> 2.94 | 2.94 (1.84–4.70) | < 0.001*** | 2.44 (1.45–4.12) | < 0.001*** |
VitD (ng/mL) | ||||
≦1.16 | Reference | |||
> 1.16 | 1.16 (0.73–1.84) | 0.527 | ||
IGF-1 (ug/L) | ||||
≦2.07 | Reference | |||
> 2.07 | 2.07 (0.76–5.67) | 0.156 | ||
Atherosclerosis | ||||
No | Reference | |||
Yes | 0.74 (0.47–1.16) | 0.186 | ||
Hypertension | ||||
No | Reference | |||
Yes | 0.89 (0.56–1.40) | 0.606 | ||
